Participants
Convergence Forum East is an invitation-only gathering of one hundred pharmaceutical executives, biotech entrepreneurs, medical device innovators, academic researchers, and life sciences investors from the Northeast and beyond. Request an invitation.
Companies represented at Convergence 2011 included:
| Abingworth Management | HepatoChem |
| Adimab LLC | Hepregen Corporation |
| Aileron Therapeutics | Highland Capital Partners |
| Alexandria Real Estate Equities | Infinity Pharmaceuticals |
| Alnylam Pharmaceuticals | Ironwood Pharmaceuticals |
| Amgen | J. Robert Scott Executive Search |
| Anchor Therapeutics | Krasner Health Strategies |
| Ascension Health Ventures | MacDougall Biomedical Communications |
| AstraZeneca R&D | Marine Biological Laboratory |
| AthenaHealth Inc. | Mass High Tech |
| Atlas Venture | Massachusetts General Hospital |
| aTyr Pharma | Merck & Co. |
| Avecia Biotechnology | MIT Media Lab |
| AVEO Pharmaceuticals | NormOxys |
| Avila Therapeutics | Novartis Molecular Diagnostics |
| Biogen Idec | Novelos Therapeutics |
| BioVax, Inc. | PatientsLikeMe Inc. |
| Bioventures Investors | Pervasis Therapeutics |
| Blue Cross Blue Shield of MA. | Polaris Venture Partners |
| Bluebird Bio | PureTech Ventures |
| Boston's Children's Hospital | Rhapsody Biologics |
| Canaan Partners | Rib-X Pharmaceuticals |
| CBT Advisors | RMG Associates |
| Celldex Therapeutics | Seaside Therapeutics |
| Clinquest, Inc. | Seracare |
| Concert Pharmaceuticals | Silicon Valley Bank |
| Constellation Pharmaceuticals | SmartCells |
| Correlation Pharmaceuticals | Spinebridge Medical |
| Cubist Pharmaceuticals | SpringLeaf Therapeutics |
| Diagnostics For All | Strategic Science & Technologies |
| Dicerna Pharmaceuticals | Stromedix |
| DUSA Pharmaceuticals | Sunovion Pharmaceuticals Inc. |
| Enlight Biosciences | Synta Pharmaceuticals |
| EpiZyme Inc. | T2 Biosystems, Inc. |
| Euthymics Bioscience | The New York Academy of Sciences |
| Excelimmune | The Tide Mill Group |
| Exelixis Inc. | Third Rock Ventures |
| Extera Partners | Topera Medical |
| Fidelity Biosciences | Tremont Therapeutics |
| Foley and Lardner LLP | Tufts Ctr. for the Study of Drug Dev. |
| Forma Therapeutics | TVM Capital |
| Genzyme | Urban Health Plan, Inc. |
| GI Dynamics | Weber Shandwick |
| GNS Healthcare | Zafgen |
| Halloran Consulting Group |